Literature DB >> 22058201

Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements.

Irene Homminga1, Maartje J Vuerhard, Anton W Langerak, Jessica Buijs-Gladdines, Rob Pieters, Jules P P Meijerink.   

Abstract

Translocation of the LYL1 oncogene are rare in T-cell acute lymphoblastic leukemia, whereas the homologous TAL1 gene is rearranged in approximately 20% of patients. Previous gene-expression studies have identified an immature T-cell acute lymphoblastic leukemia subgroup with high LYL1 expression in the absence of chromosomal aberrations. Molecular characterization of a t(7;19)(q34;p13) in a pediatric T-cell acute lymphoblastic leukemia patient led to the identification of a translocation between the TRB@ and LYL1 loci. Similar to incidental T-cell acute lymphoblastic leukemia cases with synergistic, double translocations affecting TAL1/2 and LMO1/2 oncogenes, this LYL1-translocated patient also had an LMO2 rearrangement pointing to oncogenic cooperation between LYL1 and LMO2. In hierarchical cluster analyses based on gene-expression data, this sample consistently clustered along with cases having TAL1 or LMO2 rearrangements. Therefore, LYL1-rearranged cases are not necessarily associated with immature T-cell development, despite high LYL1 levels, but elicit a TALLMO expression signature.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22058201      PMCID: PMC3269487          DOI: 10.3324/haematol.2011.051722

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  23 in total

1.  Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.

Authors:  Kamel El Omari; Sarah J Hoosdally; Kapil Tuladhar; Dimple Karia; Paresh Vyas; Roger Patient; Catherine Porcher; Erika J Mancini
Journal:  Blood       Date:  2010-11-12       Impact factor: 22.113

2.  An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.

Authors:  P D Aplan; C A Jones; D S Chervinsky; X Zhao; M Ellsworth; C Wu; E A McGuire; K W Gross
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

3.  A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.

Authors:  K M Draheim; N Hermance; Y Yang; E Arous; J Calvo; M A Kelliher
Journal:  Oncogene       Date:  2010-11-08       Impact factor: 9.867

4.  lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif.

Authors:  J D Mellentin; S D Smith; M L Cleary
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

5.  Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34.

Authors:  S D Smith; R Morgan; R Gemmell; M D Amylon; M P Link; C Linker; B K Hecht; R Warnke; B E Glader; F Hecht
Journal:  Blood       Date:  1988-02       Impact factor: 22.113

6.  Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia.

Authors:  Irene Homminga; Rob Pieters; Anton W Langerak; Johan J de Rooi; Andrew Stubbs; Monique Verstegen; Maartje Vuerhard; Jessica Buijs-Gladdines; Clarissa Kooi; Petra Klous; Pieter van Vlierberghe; Adolfo A Ferrando; Jean Michel Cayuela; Brenda Verhaaf; H Berna Beverloo; Martin Horstmann; Valerie de Haas; Anna-Sophia Wiekmeijer; Karin Pike-Overzet; Frank J T Staal; Wouter de Laat; Jean Soulier; Francois Sigaux; Jules P P Meijerink
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

7.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.

Authors:  Adolfo A Ferrando; Donna S Neuberg; Jane Staunton; Mignon L Loh; Christine Huard; Susana C Raimondi; Fred G Behm; Ching Hon Pui; James R Downing; D Gary Gilliland; Eric S Lander; Todd R Golub; A Thomas Look
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

8.  Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice.

Authors:  R C Larson; I Lavenir; T A Larson; R Baer; A J Warren; I Wadman; K Nottage; T H Rabbitts
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

9.  Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia.

Authors:  I Wadman; J Li; R O Bash; A Forster; H Osada; T H Rabbitts; R Baer
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

10.  Chromosomal translocation involving the beta T cell receptor gene in acute leukemia.

Authors:  M L Cleary; J D Mellentin; J Spies; S D Smith
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  21 in total

1.  Genetic and epigenetic studies offer new therapeutic options for the treatment of T-cell acute lymphoblastic leukemia.

Authors:  Jan Cools
Journal:  Haematologica       Date:  2012-03       Impact factor: 9.941

2.  The LMO2 oncogene regulates DNA replication in hematopoietic cells.

Authors:  Marie-Claude Sincennes; Magali Humbert; Benoît Grondin; Véronique Lisi; Diogo F T Veiga; André Haman; Christophe Cazaux; Nazar Mashtalir; El Bachir Affar; Alain Verreault; Trang Hoang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-13       Impact factor: 11.205

Review 3.  The genetics and mechanisms of T cell acute lymphoblastic leukaemia.

Authors:  Laura Belver; Adolfo Ferrando
Journal:  Nat Rev Cancer       Date:  2016-07-25       Impact factor: 60.716

4.  MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia.

Authors:  Fiona C Brown; Eric Still; Richard P Koche; Christina Y Yim; Sumiko Takao; Paolo Cifani; Casie Reed; Shehana Gunasekera; Scott B Ficarro; Peter Romanienko; Willie Mark; Craig McCarthy; Elisa de Stanchina; Mithat Gonen; Venkatraman Seshan; Patrick Bhola; Conor O'Donnell; Barbara Spitzer; Crystal Stutzke; Vincent-Philippe Lavallée; Josée Hébert; Andrei V Krivtsov; Ari Melnick; Elisabeth M Paietta; Martin S Tallman; Anthony Letai; Guy Sauvageau; Gayle Pouliot; Ross Levine; Jarrod A Marto; Scott A Armstrong; Alex Kentsis
Journal:  Cancer Discov       Date:  2018-02-05       Impact factor: 39.397

Review 5.  Breakpoint sites disclose the role of the V(D)J recombination machinery in the formation of T-cell receptor (TCR) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia.

Authors:  Nicole S D Larmonie; Willem A Dik; Jules P P Meijerink; Irene Homminga; Jacques J M van Dongen; Anton W Langerak
Journal:  Haematologica       Date:  2013-08       Impact factor: 9.941

Review 6.  Intracellular Signaling Pathways Involved in Childhood Acute Lymphoblastic Leukemia; Molecular Targets.

Authors:  Cristian Fabián Layton Tovar; Hugo Mendieta Zerón
Journal:  Indian J Hematol Blood Transfus       Date:  2015-10-20       Impact factor: 0.900

7.  GFI1B, EVI5, MYB--additional genes that cooperate with the human BCL6 gene to promote the development of lymphomas.

Authors:  Beverly W Baron; John Anastasi; Juraj Bies; Poluru L Reddy; Loren Joseph; Michael J Thirman; Kristen Wroblewski; Linda Wolff; Joseph M Baron
Journal:  Blood Cells Mol Dis       Date:  2013-07-30       Impact factor: 3.039

8.  Plant homeodomain finger protein 2 as a novel IKAROS target in acute lymphoblastic leukemia.

Authors:  Zheng Ge; Yan Gu; Qi Han; Justin Sloane; Qinyu Ge; Goufeng Gao; Jinlong Ma; Huihui Song; Jiaojiao Hu; Baoan Chen; Sinisa Dovat; Chunhua Song
Journal:  Epigenomics       Date:  2017-10-10       Impact factor: 4.778

9.  Loss-of-function mutations of Dynamin 2 promote T-ALL by enhancing IL-7 signalling.

Authors:  C S Tremblay; F C Brown; M Collett; J Saw; S K Chiu; S E Sonderegger; S E Lucas; R Alserihi; N Chau; M L Toribio; M P McCormack; M Chircop; P J Robinson; S M Jane; D J Curtis
Journal:  Leukemia       Date:  2016-04-27       Impact factor: 11.528

10.  Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors.

Authors:  Linda Zuurbier; Alejandro Gutierrez; Charles G Mullighan; Kirsten Canté-Barrett; A Olivier Gevaert; Johan de Rooi; Yunlei Li; Willem K Smits; Jessica G C A M Buijs-Gladdines; Edwin Sonneveld; A Thomas Look; Martin Horstmann; Rob Pieters; Jules P P Meijerink
Journal:  Haematologica       Date:  2013-08-23       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.